Replimune Group Inc (REPL)

11.85 -0.63 (-5.05%) USD  |  NASDAQ  |  Dec 17, 13:59
More

Replimune Group Enterprise Value: 467.36M for Dec. 16, 2024

Enterprise Value Chart

View Enterprise Value for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Pfizer Inc 200.03B
Bristol-Myers Squibb Co 155.03B
Nuvalent Inc 5.043B
NovaBay Pharmaceuticals Inc 2.054M
Palatin Technologies Inc 13.86M

Enterprise Value Related Metrics

Net Income (Quarterly) -53.06M
Total Expenses (Quarterly) 58.51M
EPS Diluted (Quarterly) -0.68
Earnings Yield -25.74%